✦ LIBER ✦

Rationale for the use of antifactor Xa in the treatment and prevention of venous and arterial thromboembolic events

✍ Scribed by L. Drouet; C. Bal dit Sollier

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rivaroxaban for the prevention and treat

✍ Alexander G.G. Turpie 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 401 KB

Aspirin in the prevention and treatment

✍ M. M. C. HOVENS; J. D. SNOEP; J. T. TAMSMA; M. V. HUISMAN 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

Novel Anticoagulants for the Prevention

✍ Ansgar Weltermann; Paul A. Kyrle; Sabine Eichinger 📂 Article 📅 2003 🏛 Springer Vienna 🌐 German ⚖ 110 KB

New Developments in the Prevention and T

✍ Graham F. Pineo 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 29 KB

Dabigatran Etexilate: A Review of Its Us

✍ Greig, Sarah L.; McKeage, Kate 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 576 KB

Dalteparin versus Enoxaparin for the pre

✍ Okoye, O. T.; Gelbard, R.; Inaba, K.; Esparza, M.; Belzberg, H.; Talving, P.; Te 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 328 KB